Weighted Average Number of Shares Outstanding, Basic of TuHURA Biosciences, Inc./NV from 30 Sep 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
TuHURA Biosciences, Inc./NV quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2010 to 30 Sep 2025.
  • TuHURA Biosciences, Inc./NV Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 50,666,430, a 316% increase year-over-year.
  • TuHURA Biosciences, Inc./NV annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 18,662,690, a 57% increase from 2023.
  • TuHURA Biosciences, Inc./NV annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 11,889,193, a 1121% increase from 2022.
  • TuHURA Biosciences, Inc./NV annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 974,000, a 96% decline from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

TuHURA Biosciences, Inc./NV Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,666,430 +38,487,908 +316% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 44,555,095 +32,376,573 +266% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 43,404,947 +31,231,215 +257% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 18,662,690 +14,325,690 +330% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 12,178,522 +12,129,522 +24754% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 12,178,522 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 12,173,732 +10,492,732 +624% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 4,337,000 +2,694,000 +164% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 49,000 -1,415,000 -97% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q1 2023 1,681,000 +698,000 +71% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q3
Q4 2022 1,643,000 +672,000 +69% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q2
Q3 2022 1,464,000 -32,817,000 -96% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2024 Q1
Q2 2022 974,000 -24,912,000 -96% 01 Apr 2022 30 Jun 2022 10-K 18 Sep 2023 2023 FY
Q1 2022 983,000 -28,290,000 -97% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q3
Q4 2021 971,000 -23,874,000 -96% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q2
Q3 2021 34,281,000 +17,175,000 +100% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q1
Q2 2021 25,886,000 +15,442,000 +148% 01 Apr 2021 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q1 2021 29,273,000 +17,856,000 +156% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q3
Q4 2020 24,845,000 +13,437,000 +118% 01 Oct 2020 31 Dec 2020 10-Q 11 Feb 2022 2022 Q2
Q3 2020 17,106,000 +9,567,000 +127% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q1
Q2 2020 10,444,000 +7,869,308 +306% 01 Apr 2020 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 11,417,000 +8,898,548 +353% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q3
Q4 2019 11,408,000 +8,983,778 +371% 01 Oct 2019 31 Dec 2019 10-Q 12 Feb 2021 2021 Q2
Q3 2019 7,539,000 +5,242,091 +228% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2021 Q1
Q2 2019 2,574,692 +488,550 +23% 01 Apr 2019 30 Jun 2019 10-K 18 Sep 2020 2020 FY
Q1 2019 2,518,452 +235,207 +10% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q3
Q4 2018 2,424,222 -20,135,012 -89% 01 Oct 2018 31 Dec 2018 10-Q 13 Feb 2020 2020 Q2
Q3 2018 2,296,909 -12,995,872 -85% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2020 Q1
Q2 2018 2,086,142 +881,434 +73% 01 Apr 2018 30 Jun 2018 10-K 09 Sep 2019 2019 FY
Q1 2018 2,283,245 -9,290,807 -80% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q3
Q4 2017 22,559,234 +11,134,749 +97% 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019 2019 Q2
Q3 2017 15,292,781 +3,990,792 +35% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2019 Q1
Q2 2017 1,204,708 -9,743,773 -89% 01 Apr 2017 30 Jun 2017 8-K 03 Jun 2019
Q1 2017 11,574,052 +496,777 +4.5% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q3
Q4 2016 11,424,485 +429,606 +3.9% 01 Oct 2016 31 Dec 2016 10-Q 14 Feb 2018 2018 Q2
Q3 2016 11,301,989 +681,520 +6.4% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q2 2016 10,948,481 +1,431,602 +15% 01 Apr 2016 30 Jun 2016 10-K 27 Sep 2017 2017 FY
Q1 2016 11,077,275 -27,899,552 -72% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q3
Q4 2015 10,994,879 -26,803,304 -71% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017 2017 Q2
Q3 2015 10,620,469 -25,830,545 -71% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2017 Q1
Q2 2015 9,516,879 -22,452,716 -70% 01 Apr 2015 30 Jun 2015 10-K 13 Sep 2016 2016 FY
Q1 2015 38,976,827 +7,317,036 +23% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q3
Q4 2014 37,798,183 +6,274,451 +20% 01 Oct 2014 31 Dec 2014 10-Q 12 Feb 2016 2016 Q2
Q3 2014 36,451,014 +5,020,448 +16% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2016 Q1
Q2 2014 31,969,595 01 Apr 2014 30 Jun 2014 10-K 16 Nov 2015 2015 FY
Q1 2014 31,659,791 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q3
Q4 2013 31,523,732 01 Oct 2013 31 Dec 2013 10-Q 12 Feb 2015 2015 Q2
Q3 2013 31,430,566 +18,460,783 +142% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2015 Q1
Q3 2012 12,969,783 +7,019,783 +118% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013 2013 Q3
Q2 2012 3,944,000 -2,006,000 -34% 01 Apr 2012 30 Jun 2012 10-K/A 20 Dec 2012 2012 FY
Q1 2012 3,944,000 -2,006,000 -34% 01 Jan 2012 31 Mar 2012 10-Q/A 05 Jun 2012 2012 Q3
Q4 2011 4,467,304 +2,467,304 +123% 01 Oct 2011 31 Dec 2011 10-Q 07 Feb 2012 2012 Q2
Q3 2011 5,950,000 0 0% 01 Jul 2011 30 Sep 2011 10-Q 10 Nov 2011 2012 Q1
Q2 2011 5,950,000 01 Apr 2011 30 Jun 2011 10-K/A 20 Dec 2012 2012 FY
Q1 2011 5,950,000 01 Jan 2011 31 Mar 2011 10-Q/A 05 Jun 2012 2012 Q3
Q4 2010 2,000,000 01 Oct 2010 31 Dec 2010 10-Q 07 Feb 2012 2012 Q2
Q3 2010 5,950,000 01 Jul 2010 30 Sep 2010 10-Q 10 Nov 2011 2012 Q1

TuHURA Biosciences, Inc./NV Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 18,662,690 +6,773,497 +57% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 11,889,193 +10,915,193 +1121% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 974,000 -24,912,000 -96% 01 Jul 2021 30 Jun 2022 10-K 18 Sep 2023 2023 FY
2021 25,886,000 +15,442,000 +148% 01 Jul 2020 30 Jun 2021 10-K 27 Sep 2022 2022 FY
2020 10,444,000 +7,869,308 +306% 01 Jul 2019 30 Jun 2020 10-K 28 Sep 2021 2021 FY
2019 2,574,692 +488,550 +23% 01 Jul 2018 30 Jun 2019 10-K 18 Sep 2020 2020 FY
2018 2,086,142 +881,434 +73% 01 Jul 2017 30 Jun 2018 10-K 09 Sep 2019 2019 FY
2017 1,204,708 -9,743,773 -89% 01 Jul 2016 30 Jun 2017 8-K 03 Jun 2019
2016 10,948,481 +1,431,602 +15% 01 Jul 2015 30 Jun 2016 10-K 27 Sep 2017 2017 FY
2015 9,516,879 -22,452,716 -70% 01 Jul 2014 30 Jun 2015 10-K 13 Sep 2016 2016 FY
2014 31,969,595 01 Jul 2013 30 Jun 2014 10-K 16 Nov 2015 2015 FY
2012 3,135,803 -2,814,197 -47% 01 Jul 2011 30 Jun 2012 10-K/A 20 Dec 2012 2012 FY
2011 5,950,000 01 Jul 2010 30 Jun 2011 10-K/A 20 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.